Table 1 Baseline characteristics of study cohort.
From: Non-ampullary duodenal neuroendocrine tumours – a tertiary referral centre experience
Variable | Level | Number (42) | Percentage (%) |
|---|---|---|---|
Demographics | |||
Age | Median (IQR) | 69 (57–77) | |
Mean | 67 | ||
Sex | Male | 19 | 45.2 |
Comorbidities | Hypertension | 17 | 40.5 |
Prior GI surgery | 2 | 4.8 | |
Coronary artery disease | 5 | 11.9 | |
Chronic renal failure | 4 | 9.5 | |
Cirrhosis | 2 | 4.8 | |
Obesity | 4 | 9.5 | |
Other ongoing malignancy (e.g.,breast) | 3 | 7.1 | |
Biochemical markers | |||
Functional status | Functional | 7 | 16.7 |
Nonfunctional | 35 | 83.3 | |
Imaging studies | |||
Staging CT/MRI findings | Normal | 13 | 31 |
Duodenal tumour with no metastasis | 23 | 54.8 | |
Multiple liver metastasis and intraabdominal nodes | 6 | 14.3 | |
Ga-SSA-PET-CT | No uptake | 24 | 57.1 |
Avid primary tumour with no metastasis | 15 | 35.7 | |
No records | 3 | 7.1 | |
Pre-resection biopsy | Well differentiated G1 | 32 | 76.2 |
Well differentiated G2 | 10 | 23.8 | |
Management | Conservative | 8 | 19.0 |
Endoscopic resection | 21 | 50.0 | |
Surgical resection | 13 | 31.0 | |
